A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy
Not yet recruiting · NCT07765537 · Registry updated 2026-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy | Primary Membranous Nephropathy | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-14 | NCT07765537 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shenzhen Fosun Kairos Biotechnology Co., Ltd. | 3 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nanjing General Hospital of Nanjing Military Command | Nanjing | China | 1 |
| Peking University People's Hospital | Beijing | China | 146 |
| Shenzhen People's Hospital | Shenzhen | China | 26 |
| Sichuan Provincial People's Hospital | Chengdu | China | 50 |
| The First affiliated Hospital of Anhui Medical University | Hefei | China | 56 |
| The First Affiliated Hospital, Sun Yat-sen University | Guangzhou | China | 32 |
| Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 11 |
| Xiangya Hospital of Central South University | Changsha | China | 47 |